MAnufacturing of TUmour-REactive Natural Killer cells

Informazioni relative al progetto

MATURE-NK

ID dell’accordo di sovvenzione: 765104

DOI

10.3030/765104

Progetto chiuso

Data della firma CE 18 Maggio 2018

Data di avvio 1 Giugno 2018

Data di completamento 30 Novembre 2022

Finanziato da

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Costo totale

€ 3 347 488,66

Contributo UE

€ 3 347 488,66

Coordinato da

MEDIZINISCHE HOCHSCHULE HANNOVER
Germany

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Other (8)

Recruitment meeting

1 - 3 rounds of recruitment meeting performed to select all ESRs.

Recruitment fellows completed

Recruitment fellows completed.

Career plans for fellows

Career plans for all individual fellows drafted according DoA Part B.

Second round second.

Second round second ments performed as outlined in DocA Part B.

Supervisory board

Supervisory board of project established.

6 Winter + Summer Schools

6 Winter and Summer Schools performed at months 8,12, 18, 24, 30 and 36 as outlined in DoA Part B.

First round secondments

First round secondments performed as outlined in DocA Part B.

Final Consortium Meeting

Final Consortium Meeting performed as outlined in DocA Part B.

Documents, reports (4)

Improved NK subset

Improved NK subset tested in vitro and suggested to WP4 and WP5.

Stimulating activat. NKR

Stimulating activat NKR evaluated in vitro and suggested to WP4 and WP5

Lessons clinical trials

Available clinical trials evaluated and lessons transmitted to WP4 and WP5.

Fortified NK cells

NK cells fortified by CAR modification or bispecific reagents tested in vitro and suggested to WP4 and WP5

Websites, patent fillings, videos etc. (3)

PhD degrees fellows

Successful PhD degrees for all fellows

Scientific publications fellows

Scientific publications fellows obtained according DoA Part B

Public dissemination events

Public dissemination events performed according DoA Part B

Pubblicazioni

Peer reviewed articles (26)

Single-Cell RNA Sequencing of Tumor-Infiltrating

Autori: Jing Ni, Xi Wang, Ana Stojanovic, Qin Zhang, Marian Wincher, Lea Bühler, Annette Arnold, Margareta P.Correia. Manuel Winkler. Philipp- Sebastian Koch. Veronika Sexl, Thomas Höfer, Adelheid Cerwenka
Pubblicato in: Immunity, Numero 52, 2020, Pagina/e 1075-1087, ISSN 1097-4180
Editore: Cell Press
DOI: 10.1016/j.immuni.2020.05.001

CD116+ fetal precursors migrate to the perinatal lung and give rise to human alveolar macrophages

Autori: Elza Evren, Emma Ringqvist, Jean-Marc Doisne, Anna Thaller, Natalie Sleiers, Richard A. Flavell, James P. Di Santo, Tim Willinger
Pubblicato in: Journal of Experimental Medicine, Numero 219, 2021, Pagina/e e20210987, ISSN 1540-9538
Editore: Rockefeller University Press
DOI: 10.1084/jem.20210987

An optimized platform for efficient siRNA delivery into human NK cells

Autori: Palacios, D., Momayyezi, P., Huhn, O., Ask, E.H., Dunst, J., Malmberg, K.-J. and Hammer, Q.
Pubblicato in: Eur. J. Immunol., Numero 52, 2022, Pagina/e 1190-1193, ISSN 0014-2980
Editore: John Wiley & Sons Ltd.
DOI: 10.1002/eji.202149710

Comprehensive analysis of nasal polyps reveals a more pronounced type 2 transcriptomic profile of epithelial cells and mast cells in aspirin-exacerbated respiratory disease

Autori: Christine Bangert, Sergio Villazala Merino, Martin Fahrenberger, Thomas Krausgruber, Wolfgang Michael Bauer, Victoria Stanek, Nicholas James Campion, Tina Bartosik, Tamara Quint, Guenther Regelsberger, Verena Niederberger-Leppin, Christoph Bock, Sven Schneider, Julia Eckl-Dorna
Pubblicato in: Frontiers in Immunology, Numero 13, 2022, Pagina/e 850494, ISSN 1664-3224
Editore: Frontiers Media S.A.
DOI: 10.3389/fimmu.2022.850494

Phenotypic and functional characterization of NK cells in αβT-cell and B-cell depleted haplo-HSCT to cure pediatric patients with acute leukemia

Autori: Raffaella Meazza, Michela Falco, Fabrizio Loiacono, Paolo Canevali, Mariella Della Chiesa, Alice Bertaina, Daria Pagliara, Pietro Merli, Valentina Indio, Federica Galaverna, Mattia Algeri, Francesca Moretta, Natalia Colomar-Carando, Letizia Muccio, Simona Sivori, Andrea Pession, Maria Cristina Mingari, Lorenzo Moretta, Alessandro Moretta, Franco Locatelli§, and Daniela Pende§. (§F.L. and D.P. e
Pubblicato in: Cancers, Numero 12, 2020, Pagina/e E2187, ISSN 2072-6694
Editore: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers12082187

Small interfering RNA delivery into primary human natural killer cells for functional gene analyses

Autori: Momayyezi, P., Malmberg, K., & Hammer, Q.
Pubblicato in: Current Protocols, Numero 2, 2022, Pagina/e e613, ISSN 2691-1299
Editore: John Wiley & Sons Inc.
DOI: 10.1002/cpz1.613

Innate-like NKp30+CD8+ T cells armed with TCR/CAR target tumor heterogeneity

Autori: Margareta P. Correia, Ana Stojanovic, Winfried S. Wels and Adelheid Cerwenka
Pubblicato in: Oncoimmunology, Numero 10, 2021, Pagina/e e1973783, ISSN 2162-4011
Editore: Landes Bioscience
DOI: 10.1080/2162402x.2021.1973783

Exploiting Natural Killer cell engagers to control pediatric B-cell precursor acute lymphoblastic leukemia

Autori: Colomar-Carando N., Gauthier L., Merli P., Loiacono F., Canevali P., Falco M., Galaverna F., Rossi B., Bosco F., Caratini M., Mingari M-C., Locatelli F., Vivier E., Meazza R.§, Pende D.§. (§ R.M. and D.P. share last authorship).
Pubblicato in: Cancer Immunol Res, Numero 10, 2022, Pagina/e 291-302, ISSN 2326-6074
Editore: American Association for Cancer Research Inc.
DOI: 10.1158/2326-6066.cir-21-0843

Human NK cells, their receptors and function

Autori: Linda Quatrini, Mariella Della Chiesa, Simona Sivori, Maria Cristina Mingari, Daniela Pende D, Lorenzo Moretta
Pubblicato in: Eur. J. Immunol., Numero 51, 2021, Pagina/e 1566–1579, ISSN 0014-2980
Editore: John Wiley & Sons Ltd.
DOI: 10.1002/eji.202049028

Genetic Engineering of Natural Killer Cells for Enhanced Antitumor Function.

Autori: Mantesso, S., Geerts, D., Spanholtz, J., & Kučerová, L.
Pubblicato in: Frontiers in Immunology, Numero 11, 2020, Pagina/e 607131, ISSN 1664-3224
Editore: Frontiers Media S.A.
DOI: 10.3389/fimmu.2020.607131

Dichotomous metabolic networks govern human ILC2 proliferation and function

Autori: Laura Surace, Jean-Marc Doisne, Carys A. Croft, Anna Thaller, Pedro Escoll, Solenne Marie, Natalia Petrosemoli, Vincent Guillemot, Valerie Dardalhon, Davide Topazio, Antonia Cama, Carmen Buchrieser, Naomi Taylor, Ido Amit, Olimpia Musumeci & James P. Di Santo
Pubblicato in: Nature Immunology, Numero 22, 2021, Pagina/e 1367-1374, ISSN 1529-2908
Editore: Nature Publishing Group
DOI: 10.1038/s41590-021-01043-8

NK cells under hypoxia: The two faces of vascularization in tumor and pregnancy

Autori: Irene Garcés Lázaro, Rebecca Kotzur, Ofer Mandelboim and Adelheid Cerwenka
Pubblicato in: Front. Immunol., Numero 13, 2022, Pagina/e 924775, ISSN 1664-3224
Editore: Frontiers Media S.A.
DOI: 10.3389/fimmu.2022.924775

NK cells and ILCs in tumor immunotherapy

Autori: Simona Sivori*, Daniela Pende*, Linda Quatrini*, Gabriella Pietra, Mariella Della Chiesa, Paola Vacca, Nicola Tumino, Francesca Moretta, Maria Cristina Mingari, Franco Locatelli, Lorenzo Moretta
Pubblicato in: Mol. Aspects Med, Numero 80, 2020, Pagina/e 100870, ISSN 0098-2997
Editore: Pergamon Press Ltd.
DOI: 10.1016/j.mam.2020.100870

Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes

Autori: Falco M, Meazza R, Alicata C, Canevali P, Muntasell A, Bottino C, Moretta L, Pende D, Lopez-Botet M.
Pubblicato in: HLA, Numero 100, 2022, Pagina/e 107-118, ISSN 2059-2310
Editore: Wiley
DOI: 10.1111/tan.14630

Inhibitory receptors and checkpoints in human NK cells, implications for the immunotherapy of cancer

Autori: Simona Sivori, Mariella Della Chiesa, Simona Carlomagno, Linda Quatrini, Enrico Munari, Paola Vacca, Nicola Tumino, Francesca Romana Mariotti, Maria Cristina Mingari, Daniela Pende§ and Lorenzo Moretta§. (§D.P. and L.M. equally contributed to this study).
Pubblicato in: Front Immunol, Numero 11, 2020, Pagina/e 2156, ISSN 1664-3224
Editore: Frontiers Media S.A.
DOI: 10.3389/fimmu.2020.02156

Notch, RORC and IL-23 signals cooperate to promote multi-lineage human innate lymphoid cell differentiation

Autori: Carys A. Croft, Anna Thaller, Solenne Marie, Jean-Marc Doisne, Laura Surace, Rui Yang, Anne Puel, Jacinta Bustamante, Jean-Laurent Casanova, James P. Di Sant
Pubblicato in: Nature Communications, Numero 13, 2022, Pagina/e 4344, ISSN 2041-1723
Editore: Nature Publishing Group
DOI: 10.1038/s41467-022-32089-3

CAR-Expressing Natural Killer Cells for Cancer Retargeting

Autori: Kloess S., Kretschmer A., Stahl L., Fricke S., Koehl U.
Pubblicato in: Transfus med and hemother, Numero 46, 2019, Pagina/e 4-13, ISSN 1424-5493
Editore: S. Karger AG
DOI: 10.1159/000495771

NK Cell-Based Immunotherapy for Hematological Malignancies

Autori: Simona Sivori, Raffaella Meazza, Concetta Quintarelli, Simona Carlomagno, Mariella Della Chiesa, Michela Falco, Lorenzo Moretta, Franco Locatelli, Daniela Pende
Pubblicato in: J Clin Med, Numero 8, 2019, Pagina/e 1702, ISSN 2077-0383
Editore: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/jcm8101702

Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia

Autori: Haroun-Izquierdo, A., Vincenti, M., Netskar, H., van Ooijen, H., Zhang, B., Bendzick, L., Kanaya, M., Momayyezi, P., Li, S., Wiiger, M.T., Hoel, H.J., Krokeide, S.Z., Kremer, V., Tjønnfjord, G., Berglund, S., Wikström, K., Blomberg, P., Alici, E., Felices, M., Önfelt, B., Valamehr, B., Ljunggren, H.G., Björklund, A, Hammer, Q., Kveberg, L., Cichocki, F., Miller, J.S., Malmberg, K-J., and Sohlb
Pubblicato in: J. Immunother Cancer, Numero 10, 2022, Pagina/e e005577, ISSN 2455-8591
Editore: Society for Immunotherapy of Cancer - BMJ Journals
DOI: 10.1136/jitc-2022-005577

Harnessing NK Cell Checkpoint-Modulating Immunotherapies

Autori: Chauhan, S.K.S.; Koehl, U.; Klöß, S.
Pubblicato in: Cancers, Numero 12, 2020, Pagina/e 1807, ISSN 2072-6694
Editore: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers12071807

NK-92 cells retain vitality and functionality when grown in standard cell culture conditions

Autori: Kotzur, R., Duev-Cohen, A., Kol, I., Reches, A., Mandelboim, O.
Pubblicato in: Plos One, Numero 17, 2022, Pagina/e e0264897, ISSN 1932-6203
Editore: Public Library of Science
DOI: 10.1371/journal.pone.0264897

Characterization of KIR+ NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA-C

Autori: Meazza R.§, Falco M.§, Canevali P., Loiacono F., Colomar-Carando N., Muntasell A., Rea A., Mingari M-C., Locatelli F., Moretta L., Lopez-Botet M.*, Pende D*. (§ R.M. and M.F. share first authorship and * M.L.-B. and D.P. share last authorship).
Pubblicato in: HLA, Numero 2022, 2022, Pagina/e 1-14, ISSN 2059-2302
Editore: Wiley Online
DOI: 10.1111/tan.14640

CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor Function

Autori: Mariona Cabo, Sara Santana-Hernández, Marcel Costa-Garcia, Anna Rea, Roberto Lozano-Rodríguez, Michelle Ataya, Francesc Balaguer, Manel Juan, Maria C Ochoa, Silvia Menéndez, Laura Comerma, Ana Rovira, Pedro Berraondo, Joan Albanell, Ignacio Melero, Miguel López-Botet, Aura Muntasell
Pubblicato in: Cancer Immunol Res, Numero 9, 2021, Pagina/e 1476-1490, ISSN 2326-6074
Editore: American Association of Cancer Research
DOI: 10.1158/2326-6066.cir-21-0030

Human ILC3 Exert TRAIL-Mediated Cytotoxicity Towards Cancer Cells

Autori: Jana-Julia Siegler, Margareta P. Correia, Tomáš Hofman, Isabel Prager, Emrullah Birgin, Nuh N. Rahbari, Carsten Watzl, Ana Stojanovic and Adelheid Cerwenka
Pubblicato in: Front. Immunol., Numero 13, 2022, Pagina/e 742571, ISSN 1664-3224
Editore: Frontiers Media S.A.
DOI: 10.3389/fimmu.2022.742571

Polarized mitochondria as guardians of NK cell fitness

Autori: Laura Surace, Jean-Marc Doisne, Pedro Escoll, Solenne Marie, Valerie Dardalhon, Carys Croft, Anna Thaller, Davide Topazio, Angelo Sparaneo, Antonia Cama, Olimpia Musumeci, Aurelio d’Ecclesia, Carmen Buchrieser, Naomi Taylor, James P. Di Santo
Pubblicato in: Blood Advances, Numero 5, 2020, Pagina/e 26-38, ISSN 2473-9537
Editore: The American Society of Hematology
DOI: 10.1182/bloodadvances.2020003458

Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myeloma

Autori: Tschan-Plessl A, Kalberer CP, Wieboldt R, Stern M, Siegler U, Wodnar-Filipowicz A, Gerull S, Halter J, Heim D, Tichelli A, Tsakiris DA, Malmberg KJ, Passweg JR, Bottos A.
Pubblicato in: Cytotherapy, Numero 4, 2021, Pagina/e 329-338, ISSN 1465-3249
Editore: Taylor & Francis
DOI: 10.1016/j.jcyt.2020.09.009